Preeclampsia, of mice and women

Physiological Genomics

Volumn 48, Issue 8, 2016, Pages 565-572

  Sones, Jenny L ^a   Davisson, Robin L ^b,c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Placenta; Preeclampsia; Trophoblast

Indexed keywords

ARGIPRESSIN; GAMMA INTERFERON; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 17; INTERLEUKIN 6; PLACENTAL GROWTH FACTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADOPTIVE TRANSFER; AFRICAN AMERICAN; AGE; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CEREBROVASCULAR ACCIDENT; ECLAMPSIA; FETUS DEATH; HISTORY; HUMAN; HYPERTENSION; INCIDENCE; INTRAUTERINE PRESSURE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MATERNAL DEATH; METABOLIC SYNDROME X; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; SMALL FOR DATE INFANT; ANIMAL; DISEASE MODEL; FEMALE; FETUS; MOUSE; PATHOLOGY; PLACENTA; PREGNANCY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETUS; HUMANS; MICE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84983761055     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00125.2015     Document Type: Article

References (60)

1. Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A brief overview of preeclampsia. J Clin Med Res 6: 1-7, 2014.
2. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ. Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011: 214365, 2011.
3. Bell MJ. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs 39: 510-518, 2010.
4. Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P, Poston L, Chappell LC. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89: 874-885, 2016.
5. Cheng MH, Wang PH. Placentation abnormalities in the pathophysiology of preeclampsia. Expert Rev Mol Diagn 9: 37-49, 2009.
6. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium- dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35: 367-372, 2000.
7. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 64: 96-103, 2003.
8. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 39: 337-342, 2002.
9. Dokras A, Hoffmann DS, Eastvold JS, Kienzle MF, Gruman LM, Kirby PA, Weiss RM, Davisson RL. Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol Reprod 75: 899-907, 2006.
10. Doridot L, Passet B, Mehats C, Rigourd V, Barbaux S, Ducat A, Mondon F, Vilotte M, Castille J, Breuiller-Fouche M, Daniel N, le Provost F, Bauchet AL, Baudrie V, Hertig A, Buffat C, Simeoni U, Germain G, Vilotte JL, Vaiman D. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 61: 662-668, 2013.
11. Dubois B, Arnold B, Opdenakker G. Gelatinase B deficiency impairs reproduction. J Clin Invest 106: 627-628, 2000.
12. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol 31: 387-411, 2013.
13. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30: 15-24, 2009.
14. Fu B, Li X, Sun R, Tong X, Ling B, Tian Z, Wei H. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 110: E231-E240, 2013.
15. Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem perinatal study. Paediatr Perinat Epidemiol 19: 59-68, 2005.
16. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50: 1142-1147, 2007.
17. Gilbert JS, Gilbert SA, Arany M, Granger JP. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53: 399-403, 2009.
18. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 122: 383-392, 2006.
19. Grill S, Rusterholz C, Zanetti-Dallenbach R, Tercanli S, Holzgreve W, Hahn S, Lapaire O. Potential markers of preeclampsia-a review. Reprod Biol Endocrinol 7: 70, 2009.
20. Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW, Jr Wallace K, LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond) 130: 409-419, 2016.
21. Herrera-Garcia G, Contag S. Maternal preeclampsia and risk for cardiovascular disease in offspring. Curr Hypertens Rep 16: 475, 2014.
22. Hoffmann DS, Weydert CJ, Lazartigues E, Kutschke WJ, Kienzle MF, Leach JE, Sharma JA, Sharma RV, Davisson RL. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia. Hypertension 51: 1058-1065, 2008.
23. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323: 1213-1217, 2001.
24. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev 71, Suppl 1: S18-S25, 2013.
25. Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 21: 943-947, 2008.
26. Kudo Y, Boyd CA, Sargent IL, Redman CW. Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. Am J Obstet Gynecol 188: 719-726, 2003.
27. Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 93: 121-127, 2016.
28. Li J, LaMarca B, Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol 303: H1-H8, 2012.
29. Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension 64: 36-44, 2014.
30. Malassine A, Frendo JL, Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 9: 531-539, 2003.
31. Maltepe E, Krampitz GW, Okazaki KM, Red-Horse K, Mak W, Simon MC, Fisher SJ. Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta. Development 132: 3393-3403, 2005.
32. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003.
33. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 156: 918-930, 2008.
34. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 6: 584-594, 2006.
35. Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J, Croy BA. Interferon gamma in successful pregnancies. Biol Reprod 80: 848-859, 2009.
36. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 291: R1085-R1093, 2006.
37. Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, Ni W, Kalluri R, Werb Z. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci USA 110: 11109-11114, 2013.
38. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 30, Suppl A: S38-S42, 2009.
39. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 46: 1243-1249, 2005.
40. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD, National Heart Lung, and Blood Institute. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 22:109-127, 2003.
41. Santillan MK, Pelham CJ, Ketsawatsomkron P, Santillan DA, Davis DR, Devor EJ, Gibson-Corley KN, Scroggins SM, Grobe JL, Yang B, Hunter SK, Sigmund CD. Pregnant mice lacking indoleamine 2,3- dioxygenase exhibit preeclampsia phenotypes. Physiol Rep 3: e12257, 2015.
42. Santillan MK, Santillan DA, Scroggins SM, Min JY, Sandgren JA, Pearson NA, Leslie KK, Hunter SK, Zamba GK, Gibson-Corley KN, Grobe JL. Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension 64: 852-859, 2014.
43. Schlager G, Sides J. Characterization of hypertensive and hypotensive inbred strains of mice. Lab Anim Sci 47: 288-292, 1997.
44. Schmid M, Sollwedel A, Thuere C, Wafula PO, Zenclussen ML, Muller DN, Gratze P, Woiciechowsky C, Volk HD, Zenclussen AC. Murine pre-eclampsia induced by unspecific activation of the immune system correlates with alterations in the eNOS and AT1 receptor expression in the kidneys and placenta. Placenta 28: 688-700, 2007.
45. Sones JL, Cha J, Woods AK, Bartos A, Heyward CY, Lob HE, Isroff CE, Butler SD, Shapiro SE, Dey SK, Davisson RL. Decidual Cox2 inhibition improves fetal and maternal outcomes in a preeclampsia-like mouse model. J Clin Invest Insight 1: e75351, 2016.
46. Sones JL, Lob HE, Isroff CE, Davisson RL. Role of decidual natural killer cells, interleukin-15, and interferon-gamma in placental development and preeclampsia. Am J Physiol Regul Integr Comp Physiol 307:R490-R492, 2014.
47. Sones JL, Zhou Y, Woods AK, Isroff CE, Knudsen MG, Davisson RL. Ovarian hormone signaling defects are associated with asynchronous peri-implantation events in a mouse model of preeclampsia, BPH/5. Reprod Sci Suppl 20: 2013.
48. Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 25: 498-507, 2012.
49. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 376: 631-644, 2010.
50. Suzuki S, Tone S, Takikawa O, Kubo T, Kohno I, Minatogawa Y. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J 355: 425-429, 2001.
51. Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 87: 134, 2012.
52. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89: 770-775, 2004.
53. Torry DS, Hinrichs M, Torry RJ. Determinants of placental vascularity. Am J Reprod Immunol 51: 257-268, 2004.
54. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia:pathophysiology, diagnosis, management. Vasc Health Risk Manag 7:467-474, 2011.
55. Wallace AE, Host AJ, Whitley GS, Cartwright JE. Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia. Am J Pathol 183: 1853-1861, 2013.
56. Wallace K, Richards S, Dhillon P, Weimer A, Edholm ES, Bengten E, Wilson M, Martin JN Jr, LaMarca B. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57: 949-955, 2011.
57. Whitehead N. Biomedicine. Proteins and a pregnancy woe. Science 345:249, 2014.
58. Williams PJ, Bulmer JN, Searle RF, Innes BA, Robson SC. Altered decidual leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: a comparison with late normal pregnancy. Reproduction 138: 177-184, 2009.
59. Woods AK, Hoffmann DS, Weydert CJ, Butler SD, Zhou Y, Sharma RV, Davisson RL. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension 57: 94-102, 2011.
60. Zenclussen AC, Fest S, Joachim R, Klapp BF, Arck PC. Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur J Immunol 34: 377-387, 2004.